FDA gives full approval to first drug to clearly, but modestly, slow Alzheimer’s
7/7/23
from The Washington Post,
7/6/23:
Leqembi, administered intravenously every other week, will get a “boxed warning” because it can cause brain bleeding and swelling
More From The Washington Post (subscription required):
